Literature DB >> 7270450

Occurrence and significance of endothelial cells in implanted porcine bioprosthetic valves.

T Ishihara, V J Ferrans, M Jones, S W Boyce, W C Roberts.   

Abstract

Histologic and scanning and transmission electron microscopic studies were made to determine the frequency of occurrence of endothelial cells in 49 porcine valve bioprostheses removed from 43 patients 2 days to 113 months (average 35 months) after implantation. Endothelial cells were found in none of 17 bioprostheses in place for less than 1 year, in 5 (23 percent) of 22 in place for 1 to 5 years and in 7 (70 percent) of 10 in place for longer than 5 years. The 12 bioprostheses in which endothelial cells were present had been implanted in the atrioventricular position (7 of 32 in the mitral position and 5 of 6 in the tricuspid position) for 21 to 113 months (average 71). Endothelial cells were not found in any of 11 bioprostheses implanted in the semilunar position (9 in the aortic position and 2 in pulmonary conduits); however, all but one of these bioprostheses had been in place for less than 5 years. Endothelial cells were concentrated along the basal regions of the cusps. These cells did not grow in direct contact with valve collagen, but were attached to fibrin, thrombi or fibroelastic host tissue (fibrous sheath) on the valve surfaces. The growth of endothelial cells and associated fibrous tissue may serve to increase the structural stability of bioprosthetic valve cusps, which may be of functional importance several years after implantation when the porcine connective tissue may have undergone significant deterioration.

Entities:  

Mesh:

Year:  1981        PMID: 7270450     DOI: 10.1016/0002-9149(81)90071-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Experimental study on modified treatment and endothelialization of bovine pericardial valves.

Authors:  P Fu; H Lan; D Wang; H Guan
Journal:  J Tongji Med Univ       Date:  1997

2.  Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration.

Authors:  Mario Lopez-Moya; Pedro Melgar-Lesmes; Kumaran Kolandaivelu; Jose María de la Torre Hernández; Elazer R Edelman; Mercedes Balcells
Journal:  Biomacromolecules       Date:  2018-03-20       Impact factor: 6.988

3.  Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep.

Authors:  G R Barnhart; M Jones; T Ishihara; D M Rose; A M Chavez; V J Ferrans
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

4.  Degenerative processes in bioprosthetic mitral valves in juvenile pigs.

Authors:  Jesper L Honge; Jonas A Funder; Torben B Pedersen; Mads B Kronborg; J Michael Hasenkam
Journal:  J Cardiothorac Surg       Date:  2011-05-15       Impact factor: 1.637

Review 5.  Heart valve tissue engineering: concepts, approaches, progress, and challenges.

Authors:  Karen Mendelson; Frederick J Schoen
Journal:  Ann Biomed Eng       Date:  2006-10-12       Impact factor: 3.934

Review 6.  The path to a hemocompatible cardiovascular implant: Advances and challenges of current endothelialization strategies.

Authors:  Vasileios Exarchos; Ema Zacharova; Sebastian Neuber; Costanza Giampietro; Sarah E Motta; Hristian Hinkov; Maximilian Y Emmert; Timo Z Nazari-Shafti
Journal:  Front Cardiovasc Med       Date:  2022-09-14

7.  Microbiological etiology in prosthetic valve endocarditis: A nationwide registry study.

Authors:  Blerand Berisha; Sigurdur Ragnarsson; Lars Olaison; Magnus Rasmussen
Journal:  J Intern Med       Date:  2022-04-19       Impact factor: 13.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.